利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

15 条记录 (耗时 0.032 秒)

    7-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
    8.
    发明授权
    7-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials 失效
    7-取代的3-羧基 - 恶二唑 - 喹诺酮衍生物，其制备及其作为抗菌剂的应用

    公开(公告)号：US07713965B2

    公开(公告)日：2010-05-11

    申请号：US12394918

    申请日：2009-02-27

    申请人： Paola Ciapetti ,  Florence Chery-Mozziconacci ,  Camille G. Wermuth ,  Françoise Leblanc ,  Marc Schneider ,  Sandrine Ropp ,  Christophe Morice ,  Bruno Giethlen

    发明人： Paola Ciapetti ,  Florence Chery-Mozziconacci ,  Camille G. Wermuth ,  Françoise Leblanc ,  Marc Schneider ,  Sandrine Ropp ,  Christophe Morice ,  Bruno Giethlen

    IPC分类号： C07D498/06 ,  A61K31/5365

    CPC分类号： C07D498/06

    摘要： A subject of the invention is the compounds of formula (I): in which either R1 represents H, OH, NH2, —(CH2)m—NRaRb(m=0.1 or 2), Ra and Rb represent H, linear, branched or cyclic (C1-C6) alkyl, (C3-C6) cycloalkyl-(C3-C6)— alkyl, Rc, S(O)2Rc, C(O)Rc, S(O)2Rd or C(O)Rd; or Ra and Rb with N form an Rc radical; Rc represents a saturated, unsaturated or 5- or 6-members aromatic ring, containing 1 to 4 heteroatoms chosen from N, O and S, optionally substituted; Rd represents a linear, branched or cyclic (C1-C6) alkyl, optionally substituted by 1 to 4 halogens; or R1 represents Rc or CHReRc or CHReRd; Re represents H, OH, NH2, NH—(C1-C6)-alk or N-(C1-C6)-alk2, or NH—(C1-C7)-acyl or NHRc; R2 represents H, (CH2)m—NRaRb, Rc, CHReRc or CHReRd, and R′2 represents H.

    摘要翻译： 本发明的主题是式（I）的化合物：其中R 1表示H，OH，NH 2， - （CH 2）m -NR a R b（m = 0.1或2），R a和R b表示H，直链，支链或 环（C 1 -C 6）烷基，（C 3 -C 6）环烷基 - （C 3 -C 6） - 烷基，R c，S（O）2 C，C（O）R c，S（O）2 R d或C（O） 或R a和R b与N形成R c基团; Rc表示饱和，不饱和或5-或6-元芳环，其含有1至4个选自N，O和S的杂原子，任选地被取代; Rd表示任选被1至4个卤素取代的直链，支链或环状（C 1 -C 6）烷基; 或R1表示Rc或CHRRR或CHRRR; Re表示H，OH，NH2，NH-（C1-C6）-alk或N-（C1-C6）-alk2或NH-（C1-C7） - 酰基或NHRc; R2表示H，（CH2）m-NRaRb，Rc，CHReRc或CHReRd，R'2表示H.

    Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol and applications thereof
    9.
    发明授权
    Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol and applications thereof 失效
    14.15-二氢20.21-二烧烤蛋白-14-醇的衍生物及其应用

    公开(公告)号：US07354918B2

    公开(公告)日：2008-04-08

    申请号：US11581950

    申请日：2006-10-13

    申请人： Paola Ciapetti ,  Laurence Deyon ,  Camille-Georges Wermuth ,  Jean-François Pujol ,  Dinah Weissmann

    发明人： Paola Ciapetti ,  Laurence Deyon ,  Camille-Georges Wermuth ,  Jean-François Pujol ,  Dinah Weissmann

    IPC分类号： A61K31/5377 ,  A61K31/4375 ,  C07D413/14 ,  C07D471/22

    CPC分类号： C07D461/00

    摘要： The invention relates to novel derivatives of 14,15-dihydro 20,21-dinoreburnamenin-14-ol, having formula (I) in which R represents a radical —AR′ wherein A represents a heteroatom and R′ represents a group selected from the group comprising linear or branched C1-C6 alkyl radicals, C2-C6 alkenyls, C2-C6 alkynyls, arylalkyls; esters comprising the formula —R1— CO—O—R2; amides comprising the formula —R3—CO—NZY, wherein Y and Z together can form a cycloalkyl radical or a heterocyclic radical, optionally substituted by one or more alkyl radicals; a radical selected from the group comprising alkyl radicals, alkenyls or alkynyls, substituted by at least one amine with formula —NZY; or one of the pharmaceutically-acceptable salts thereof, including the isomers, enantiomers and diastereoisomers thereof and mixtures thereof. The invention also relates to the use of the novel derivatives for the preparation of a pharmaceutical composition which is intended, in particular, for the treatment and/or prevention of depression, sleep-wake cycle disorders and symptomatic frontal disorders in cognitive components among humans.

    摘要翻译： 本发明涉及具有式（I）的式14所示的衍生物，其中R表示自由基-AR'，其中A表示杂原子，R'表示选自 包括直链或支链C 1 -C 6烷基，C 2 -C 6亚烷基，C 2 -C 6亚烷基， C 2 -C 6炔基，芳基烷基; 包含式-R 1 -CO-O-R 2的酯; 酰胺，其包含式-NR 3 -CO-NZY，其中Y和Z一起可以形成任选被一个或多个烷基取代的环烷基或杂环基; 选自由至少一个具有式-NZY的胺取代的烷基，烯基或炔基的基团; 或其药学上可接受的盐之一，包括其异构体，对映体和非对映异构体及其混合物。 本发明还涉及新型衍生物用于制备药物组合物的用途，其特别用于治疗和/或预防人类中认知成分中的抑郁症，睡眠 - 苏醒循环障碍和症状性前额症。